Sinovac vaccine to expand annual production capacity to 2 billion

Workers at the production line of Sinovac COVID-19 vaccine facility. /CFP

China's Sinovac Biotechis expected to expand its annual production capacity of CoronaVacto 2 billion doses, as a third production line was completed and put into production on Thursday, announced the company on Friday.

More than 200 million doses of CoronaVac, an inactivated COVID-19 vaccine developed by Sinovac, including the semi-finished ones, have been delivered to in China and 26 other countries and regions. Over 100 million doses have been administered around the globe. So far, the Sinovac vaccine has received emergency use approval or conditional marketing authorization from more than 30 countries, according to the company.

Source(s): Xinhua News Agency